Heart failure affects more than 64 million people worldwide (1%โ€“3% in the general adult population) and its prevalence is projected to increase. Healio: Wegovy improves functional class in patients with obesity, heart failure at 1 year Wegovy improves functional class in patients with obesity, heart failure at 1 year Healio: FDA approves expanded indication of furosemide injection for NYHA class IV heart failure FDA approves expanded indication of furosemide injection for NYHA class IV heart failure Morning Overview on MSN: Oxford AI model predicts heart failure risk 5 years ahead at 86% Oxford AI model predicts heart failure risk 5 years ahead at 86% Cardiac CT-based heart failure prediction could enable earlier prevention. Discover how fat radiomics improves risk detection.

Understanding the Context

The American Journal of Managed Care: Finerenone Reduces Clinical Events in Patients With Heart Failure Regardless of CHD History Coronary heart disease (CHD) is one of the most common comorbidities in patients with heart failure (HF) with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), yet its prognostic and ... Finerenone Reduces Clinical Events in Patients With Heart Failure Regardless of CHD History